Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
Department of Health and Human Services
Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) invites grant applications proposing exploratory research projects focused on further development and technical validation of emerging technologies offering novel capabilities for the molecular or cellular characterization of cancer or for improved handling and quality control of biospecimens used for basic, clinical, or epidemiological cancer research. This NOFO solicits R33 applications where major feasibility gaps for the technology or methodology have been overcome, as demonstrated with supportive preliminary data, but still require further development and rigorous technical validation to encourage ado
Funding
Award size
$100K – $1M
Award ceiling
300000
Type
Grant
Dates
Deadline
Later
Posted
06/03/2026
Closes
2026-11-10
Eligibility
Eligibility
Independent school districtsPublic and State controlled institutions of higher educationNative American tribal organizations (other than Federally recognized tribal governments)Public housing authorities/Indian housing authoritiesCounty governmentsNonprofits having a 501(c)(3) status with the IRS, other than institutions of higher educationSpecial district governmentsNonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher educationFor profit organizations other than small businessesState governmentsSmall businessesCity or township governmentsOthers (see text field entitled "Additional Information on Eligibility" for clarification)Private institutions of higher educationNative American tribal governments (Federally recognized)
Program
Funding area
Health - HL
Opportunity #
RFA-CA-27-002
Source
Status
Open
Market
Government
Level
Federal
Source
Grants.gov